|
HY-P9968-1mg
|
MedChemexpress LLC
|
Nimotuzumab [CAS 780758-10-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-P9968-5mg
|
MedChemexpress LLC
|
Nimotuzumab [CAS 780758-10-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99756-1mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99756-10mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99756-5mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99763-1mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
|
HY-P99763-10mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
|
HY-P99763-5mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
|
HY-P9950-1mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P9950-5mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99406-1mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99406-10mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99406-5mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99395-1mg
|
MedChemexpress LLC
|
Talacotuzumab [CAS 1826831-79-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P99573-1mg
|
MedChemexpress LLC
|
Tebotelimab [CAS 2245725-04-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99573-10mg
|
MedChemexpress LLC
|
Tebotelimab [CAS 2245725-04-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99573-5mg
|
MedChemexpress LLC
|
Tebotelimab [CAS 2245725-04-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99333-1mg
|
MedChemexpress LLC
|
Volociximab [CAS 558480-40-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P99333-10mg
|
MedChemexpress LLC
|
Volociximab [CAS 558480-40-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P99333-5mg
|
MedChemexpress LLC
|
Volociximab [CAS 558480-40-3]
|
|
Cancer-programmed cell death
|
|
|
HY-P99382-1mg
|
MedChemexpress LLC
|
Vopratelimab [CAS 2039148-04-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99382-10mg
|
MedChemexpress LLC
|
Vopratelimab [CAS 2039148-04-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99382-5mg
|
MedChemexpress LLC
|
Vopratelimab [CAS 2039148-04-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99155-1mg
|
MedChemexpress LLC
|
ZalutuMu mab [CAS 667901-13-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99155-10mg
|
MedChemexpress LLC
|
ZalutuMu mab [CAS 667901-13-5]
|
|
Cancer-Kinase/protease
|
|
